Trump signs executive actions to boost domestic drug manufacturing and oversight of gain-of-function research, raising concerns over potential higher costs and shortages.
U.S. halts new research grants to Harvard amid compliance dispute over alleged violations and antisemitic incidents on campus.
U.S. Treasury Secretary defends Trump's economic agenda of tariffs, tax cuts, and deregulation as a strategy to attract global investment, despite skepticism from business leaders and economists.
Trump signs executive actions to boost domestic drug manufacturing and oversight of gain-of-function research, raising concerns over potential higher costs and shortages.
U.S. halts new research grants to Harvard amid compliance dispute over alleged violations and antisemitic incidents on campus.
U.S. Treasury Secretary defends Trump's economic agenda of tariffs, tax cuts, and deregulation as a strategy to attract global investment, despite skepticism from business leaders and economists.